How does StepStone make money?
STERIS plc operates as a global leader in infection prevention, contamination control, and surgical support products, generating its revenue through a diversified model spanning capital equipment, consumable supplies, and specialized outsourced services. The corporation makes money by manufacturing and selling high-performance medical devices, surgical tables, automated sterilizers, and connectivity solutions to hospitals, ambulatory surgery centers, and pharmaceutical laboratories. Furthermore, STERIS earns significant recurring revenue by providing contract sterilization services for medical device and pharmaceutical manufacturers, selling single-use consumable infection prevention items like detergents and gastrointestinal accessories, and offering long-term equipment maintenance and instrument repair contracts.
Related FAQs
StepStone Group operates as a global private markets investment firm and advisory specialist, generating its substantial revenues primarily through two distinct fee streams.
Taylor Wimpey ranks among the largest and most prominent residential home construction companies in the United Kingdom, recognized for building thousands of homes annually across diverse regional markets.
Sumitomo Corporation operates with a massive consolidated global workforce of approximately eighty-two thousand four hundred eighty-eight employees within the general trading, metals, media, and infrastructure sectors.
Purchasing a Polymerase Chain Reaction (PCR) machine or thermal cycler involves varying costs depending on whether the unit is a basic instructional block cycler or an advanced real-time qPCR system.
Executive compensation for the chief executive officer guiding STERIS plc (a leading global provider of infection prevention and other procedural products and services) reflects medical technology sector benchmarks.
As of the close of the trading session on July 24, 2026, the stock price for STERIS plc (STE) was $214.07 per share.